CANARIABIO Inc.

Equities

A016790

KR7016790008

Fishing & Farming

End-of-day quote Korea S.E. 06:00:00 2024-02-28 pm EST 5-day change 1st Jan Change
994 KRW +8.52% Intraday chart for CANARIABIO Inc. -.--% -80.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index CI
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis MT
CANARIABIO Inc. announced that it has received KRW 4.999995308 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it expects to receive KRW 4.999995308 billion in funding from CANARIABIO M Inc. CI
Specialised Therapeutics Asia Pte Ltd Signs Exclusive License Agreement with CanariaBio for New Ovarian Cancer Therapy CI
CanariaBio Inc. Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer CI
CANARIABIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
An Unknown buyer agreed to acquire 2.133768% stake in CANARIABIO Inc. from CANARIABIO M Inc. for KRW 14 billion. CI
CANARIABIO Inc. announced that it has received KRW 15 billion in funding from AT semicon Co., Ltd. CI
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from AT semicon Co., Ltd. CI
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from CANARIABIO Inc. CI
CANARIABIO Inc. announced that it has received KRW 30 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it has received KRW 20 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it expects to receive KRW 20 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it expects to receive KRW 30 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc. CI
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd. CI
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd. CI
CANARIABIO Inc.(KOSDAQ:A016790) added to S&P Global BMI Index CI
CANARIABIO Inc. announced that it has received KRW 295.63641352 billion in funding CI
HYUNDAI FEED Inc. announced that it has received KRW 31.02834072 billion in funding from CANARIABIO Inc. CI
HYUNDAI FEED Inc. announced that it has received KRW 6.326708864 billion in funding CI
Hyundai Feed to Raise $4.9 Million Through Stock Sale MT
HYUNDAI FEED Inc. announced that it expects to receive KRW 6.326708864 billion in funding CI
HYUNDAI FEED Inc. announced that it has received KRW 386.0765 billion in funding from CANARIABIO Inc. CI
Chart CANARIABIO Inc.
More charts
CanariaBio Inc, formerly Hyundai Feed Inc, is a Korea-based company mainly engaged in the manufacture and sale of livestock feeds. The Company operates its business through two segments. The Feed segment is mainly engaged in the production and sale of products such as poultry feeds, pig feeds, quail feeds, and other feeds. The Other segment is mainly engaged in the manufacture and sale of raw materials. The Company is also engaged in the rental of real estate. The Company sells its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A016790 Stock
  4. News CANARIABIO Inc.
  5. Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis